Washington State University researchers have found a mechanism by which omega-3 fatty acids inhibit the growth and spread of prostate cancer cells. The findings, which are at odds with a 2013 study asserting that omega-3s ...
Mar 18, 2015
2
140
Genetically modifying cancer cells can aid in clarifying new cancer drugs' mechanism of action, according to a new study by researchers at KU Leuven's Laboratory of Virology and Chemotherapy (Rega Institute).
Mar 4, 2015
0
11
(HealthDay)—U.S. Food and Drug Administration approval of Opdivo (nivolumab) has been expanded to include advanced non-small cell lung cancer (NSCLC), the agency said Wednesday in a news release.
Mar 4, 2015
0
2
Individuals previously infected with the hepatitis B virus (HBV) who receive chemotherapy or immunosuppressive treatment may be at risk of reactivating the disease according to a summary of report from the Emerging Trends ...
Feb 5, 2015
0
8
(HealthDay)—Higher vitamin D levels in patients with advanced colon cancer appear to improve response to chemotherapy and targeted anti-cancer drugs, researchers say.
Jan 13, 2015
0
41
(HealthDay)—Common painkillers, including ibuprofen, might slightly reduce your risk of developing a form of skin cancer, researchers say.
Dec 18, 2014
0
0
The system that allows patients rapid access to expensive new treatments lacks transparency and penalises small and low-income countries unable to negotiate lower prices with pharmaceutical manufacturers. Writing in the Journal ...
Dec 8, 2014
0
0
In the race to find more effective ways to treat cancer, Boise State biophysicist Daniel Fologea is working outside the rules of general mathematics that say one plus one equals two. In his world, one plus one adds up to ...
Sep 12, 2014
0
0
Researchers at the University of California, San Diego School of Medicine, in partnership with the California Institute for Regenerative Medicine (CIRM) and Celgene Corporation, a New Jersey-based biopharmaceutical company, ...
Sep 3, 2014
0
0
A multi-institutional team of researchers has pinpointed exactly what goes wrong when chronic lymphocytic leukemia (CLL) patients develop resistance to ibrutinib, a highly effective, precisely targeted anti-cancer drug. In ...
May 28, 2014
0
0
